Loading Curie Briefs...
Getting the latest healthcare news for you
Getting the latest healthcare news for you
Good news for reproductive health: a major Finnish study found that HPV vaccination in adolescence — whether early or late — does not raise the risk of miscarriage or other early pregnancy complications. In fact, vaccinated women had notably lower miscarriage rates than their unvaccinated peers. The findings offer strong reassurance for patients and clinicians alike.
Worried about HPV shots and pregnancy? A large, long-term Finnish study says there's no cause for concern. Researchers tracked nearly 40,000 women over 11 years and found that HPV vaccination — given either in early adolescence (ages 12–15) or as a "cross-vaccination" at around age 18.5 — was not associated with a higher risk of miscarriage or other adverse early pregnancy outcomes.
If anything, the numbers told a reassuring story: miscarriage rates were actually lower in vaccinated women compared to unvaccinated controls, though the authors caution that lifestyle and health-awareness differences between groups may play a role.
By the Numbers:
Why it matters: Vaccine hesitancy around reproductive concerns remains a real barrier to HPV uptake. This study — one of the longest follow-ups of its kind — provides clinicians with solid evidence to reassure adolescent patients and their parents that HPV vaccination poses no reproductive safety risk.
